Alpa Laboratories Ltd (ALPA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532878 | NSE: ALPA | Pharmaceuticals & Drugs | Small Cap

Alpa Lab Share Price

83.44 -0.71 -0.84%
as on 05-Dec'25 12:15

Alpa Laboratories Ltd (ALPA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532878 | NSE: ALPA | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Alpa Lab

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Alpa Laboratories stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
9.41
Market Cap:
177.1 Cr.
52-wk low:
76.3
52-wk high:
137.4

Is Alpa Laboratories Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Alpa Lab: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Alpa Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 10.3%9.5%7%4.8%4.8%9.5%15.5%11.3%13.4%15%-
Value Creation
Index
-0.3-0.3-0.5-0.7-0.7-0.30.1-0.20.00.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 53.563.462.3788697.611293109112110
Sales YoY Gr.-18.5%-1.8%25.2%10.2%13.5%15.1%-17.2%17%3.4%-
Adj EPS 3.53.32.212.32.63.74.27.79.19
YoY Gr.--5.7%-33.1%-55.9%135.7%10.8%43.8%15.2%82.3%17.5%-
BVPS (₹) 44.846.849.150.452.455.962.6697786.492.1
Adj Net
Profit
7.474.72.14.95.47.78.916.319.119
Cash Flow from Ops. -24.8-8.1-7.3-0.717.7-1.52.210.23.718.4-
Debt/CF from Ops. -1-1.3-0.8-2.50-0.12.70.31.40-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 8.6%5.5%0.1%3.4%
Adj EPS 11.1%31.5%35.1%17.5%
BVPS7.6%10.5%11.4%12.3%
Share Price 0.5% 18.2% 9.6% -31%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
8.27.34.624.54.76.26.510.611.110
Op. Profit
Mgn %
11.711.26.71.66.98.99.58.77.54.5-1.9
Net Profit
Mgn %
13.9117.52.75.75.56.99.6151717.1
Debt to
Equity
0.30.10.100000000
Working Cap
Days
403432356280238222224279241246290
Cash Conv.
Cycle
1461471481261068297154141140220

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Alpa Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 9 8.9
TTM Sales (₹ Cr.) 110 111
BVPS (₹.) 92.1 87.1
Reserves (₹ Cr.) 173 162
P/BV 0.91 0.97
PE 9.41 9.49
From the Market
52 Week Low / High (₹) 76.25 / 137.40
All Time Low / High (₹) 5.50 / 144.60
Market Cap (₹ Cr.) 177
Equity (₹ Cr.) 21
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Alpa Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Alpa Lab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Alpa Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales54636278869811293109112
Operating Expenses 47565877839010285101107
Manufacturing Costs3344456776
Material Costs28363649515970556870
Employee Cost 791012121212121314
Other Costs 98912151314111317
Operating Profit 67413811885
Operating Profit Margin (%) 11.7%11.2%6.3%1.6%4.0%7.9%9.5%8.7%7.5%4.5%
Other Income 7755341191523
Interest 1211000000
Depreciation 1111112122
Exceptional Items 0-200000000
Profit Before Tax 1197551120162126
Tax 3322145346
Profit After Tax 86534714131720
PAT Margin (%) 14.5%9.4%7.7%3.8%4.7%7.4%12.6%13.6%15.4%17.5%
Adjusted EPS (₹)3.72.92.31.41.93.56.76.08.09.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 9498103106110118132145162182
Share Capital 21212121212121212121
Reserves 737782858996111124141161
Minority Interest0000000000
Debt241161004140
Long Term Debt0010002100
Short Term Debt241051002040
Trade Payables19141313142515151219
Others Liabilities 105486814171432
Total Liabilities 147128126129130150165178192233

Fixed Assets

Gross Block25262829303134334051
Accumulated Depreciation20212223242325262831
Net Fixed Assets 556667971121
CWIP 0000120000
Investments 2223415968628689109129
Inventories15131414131715131418
Trade Receivables34292530253538474147
Cash Equivalents 35362116101912
Others Assets 36221819121715131617
Total Assets 147128126129130150165178192233

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -25-8-7-118-1210418
PBT 1197551120162126
Adjustment -1-3-1-141-8-1-10-16
Changes in Working Capital -31-11-11-210-10-6-0-412
Tax Paid -3-3-2-2-1-3-4-4-4-4
Cash Flow From Investing Activity -71-16-15-116-161-12-12
Capex -0-1-2-1-3-3-2-1-6-11
Net Investments -12-3-18-12-128-15-0-9-3
Others 664-2312322
Cash Flow From Financing Activity -6-24-5-1-05-32-5
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 000-0-0-020-10
Interest Paid -1-2-1-1-0-0-0-0-0-0
Dividend Paid 0000000000
Others -4-15-4-104-33-5
Net Cash Flow -37-9-19-2054-88-60

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)8.566.214.722.823.776.3811.349.1210.9311.45
ROCE (%)10.349.56.984.784.839.5415.5411.3313.3814.96
Asset Turnover Ratio0.420.460.490.610.660.70.710.540.590.53
PAT to CFO Conversion(x)-3.13-1.33-1.4-0.334.5-0.140.140.770.240.9
Working Capital Days
Receivable Days187183160129115112119168149143
Inventory Days72817865565452554451
Payable Days1811641369796118104997279

Alpa Laboratories Ltd Stock News

Alpa Laboratories Ltd FAQs

The current trading price of Alpa Lab on 05-Dec-2025 12:15 is ₹83.44.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Alpa Lab stood at ₹177.1.
The latest P/E ratio of Alpa Lab as of 04-Dec-2025 is 9.41.
The latest P/B ratio of Alpa Lab as of 04-Dec-2025 is 0.91.
The 52-week high of Alpa Lab is ₹137.4 and the 52-week low is ₹76.25.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Alpa Lab is ₹110.0 ( Cr.) .

About Alpa Laboratories Ltd

Incorporated as Alpa Laboratories Private Limited on March 18, 1988 under the Companies Act, 1956 and converted to public limited company on September 3, 1998 with the name of Alpa Laboratories Limited. The company has been listed on the Bombay Stock Exchange and the National Stock Exchange since August 6, 2007.

Alpa Laboratories Limited is a WHO-GMP and ISO 9001:2000 certified company located at Pigdamber, about 15 kilometers from the city of Indore in Central India. The company has been manufacturing Pharmaceutical Finished Dosage Forms since 1967. With its focus on quality, the company has earned tremendous faith and confidence of its associates.

The manufacturing facility is less than 20 kilometers from the center of the city of Indore in Central India and is spread over 1.20 acres. The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. The production areas are designed to maximize output quality and quantity with minimal down time.

The facility is WHO-GMP certified and all manufacturing areas are supplied with independent air supply systems for individual department. The independent supply systems are fed with separate air handling units to avoid cross contamination. Pressure gradients are maintained and monitored and the required air quality of class 100, 1000, 10,000 and class 100,000 is maintained.

Business area of the company

The company manufactures a wide range of products under its own brand and for a number of other reputed Indian and multinational companies. The product range includes a wide variety of ethical, generic and over the counter (OTC) drugs in various Finished Dosage Forms for both human and veterinary use.

Products

Capsules: Equipment used for the production of hard-gelatin capsules are automatic filling machine, feeder, sorter, inspection machine and polishing machine. The filled capsules are packed in high speed automatic strip and blister packing machines suitable for various sizes. The company has the ability to produce both powder filled and granule filled capsules.

Creams, Gels & Ointments: The semi-automatic machines perform the entire process of filling, sealing & crimping of the tubes in various tube sizes of Creams, Gels, Ointments, Sterile Ophthalmic Ointments and Sterile intra-mammary infusions.

Ear & Eye Drops: This department houses sophisticated machines such as automatic sealing, capping, labeling, carton forming and wrapping machines.

Injections: The parenteral is produced in a sterile area and fed to the automatic machines for ampule or vial filling, rubber bunging and cap sealing. A similar process is used for dry powder injections.

Tablets: Rapid Mixer Granulator and Fluid Bed Dryer are used to produce the material for compression in various shapes which is carried out at various multi-station, single and double rotary tablet compression machines. There are coating machines for various types of coating of the tablets. A similar process is used for boluses.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×